Natural Alternatives International (NASDAQ:NAII) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a research note issued to investors on Monday. The firm issued a buy rating on the stock.

Natural Alternatives International Price Performance

NASDAQ NAII opened at $4.31 on Monday. The company has a market capitalization of $26.72 million, a PE ratio of -2.99 and a beta of 0.58. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.59 and a current ratio of 2.56. The business’s fifty day moving average is $5.12 and its 200 day moving average is $5.71. Natural Alternatives International has a fifty-two week low of $4.13 and a fifty-two week high of $7.37.

Natural Alternatives International (NASDAQ:NAII) last posted its quarterly earnings results on Friday, September 27th. The company reported ($0.32) EPS for the quarter. The business had revenue of $29.49 million for the quarter. Natural Alternatives International had a negative net margin of 7.53% and a negative return on equity of 10.23%.

Institutional Investors Weigh In On Natural Alternatives International

A hedge fund recently raised its stake in Natural Alternatives International stock. Geode Capital Management LLC raised its holdings in shares of Natural Alternatives International, Inc. (NASDAQ:NAII) by 6.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,062 shares of the company’s stock after acquiring an additional 2,915 shares during the quarter. Geode Capital Management LLC owned approximately 0.73% of Natural Alternatives International worth $258,000 as of its most recent SEC filing. 32.40% of the stock is owned by institutional investors and hedge funds.

About Natural Alternatives International

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.